ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Depletion of Sorcs3 Activates Totipotency in Mouse Embryonic Stem Cells by Modulating Key Signaling Pathways.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Depletion of Sorcs3 Activates Totipotency in Mouse Embryonic Stem Cells by Modulating Key Signaling Pathways.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Totipotency represents the greatest potential to yield an entire individual alongside its associated extraembryonic tissues, albeit transiently. Nevertheless, achieving sustainable totipotent stem cells remains an intriguing yet challenging endeavor. Here, it is reported that Sorcs3 depletion in murine embryonic stem cells (ESCs) enables robust differentiation into both embryonic and extraembryonic lineages, resulting in a totipotent-like state. Notably, Sorcs3 knockout (SKO)-ESCs can efficiently self-assemble into typical blastocyst-like structures, offering a versatile model for studying early embryonic development. Comprehensive analyses reveal that totipotency in SKO-ESCs is related to Tfap2c gene activation. Deletion of Tfap2c significantly reduces the developmental potential of SKO-ESCs across all the examined phenotypes, underscoring its critical role. Furthermore, single-cell transcriptome analysis of SKO-ESCs reveals that inhibition of the TGF-β, PI3K-AKT, and lysosome pathways drives totipotency activation, which is validated by the introduction of corresponding inhibitors into wild-type ESC cultures. Together, the findings facilitate the establishment of totipotent stem cells in a defined medium and provide a universal platform for studying totipotency.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.